Company · CIK 0001365916
AMYRIS, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/AAMYRIS, INC.0001193125-24-133435 · 106.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-132953 · 158.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-106956 · 149.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-089614 · 151.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001365916-24-000011 · 75.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001365916-24-000008 · 1.6 MBSEC(opens sec.gov)
- SC 13D/AAMYRIS, INC.0001193125-24-003393 · 124.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001365916-24-000003 · 284.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001365916-23-000151 · 89.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001365916-23-000149 · 176.9 KBSEC(opens sec.gov)
Insiders
- Alexander RalphDirector
- Al Thani Sheikh Abdullah bin KhalifaDirector
- ALVAREZ EDUARDOCHIEF OPERATING OFFICER
- ASADORIAN RAFFIChief Financial Officer
- Boisseau PhilippeDirector
- Boynton PeterChief Commercial Officer
- Canhill Investments Pte. Ltd.10% Owner
- Cherry JoelPresident of R&D
- CHUA NAM HAI DRDirector
- Diniz Paulo Sergio de OliveiraInterim Chief Financial Officr
Tickers
No tickers on record.
Addresses
business
5885 HOLLIS STREET, SUITE 100
EMERYVILLE, CA, 94608
mailing
5885 HOLLIS STREET, SUITE 100
EMERYVILLE, CA, 94608
Former names
- AMYRIS BIOTECHNOLOGIES INC2010-05-25
Same industry